Adlai Nortye 集团

最新新闻

• 评级变动
  Adlai Nortye Ltd. Sponsored ADR (ANL) Receives a Buy From Cantor Fitzgerald
  TipRanks · 2026/7/20
• 评级变动
  Cantor Fitzgerald Initiates Adlai Nortye(ANL.US) With Buy Rating, Announces Target Price $28
  \u5e02\u573a\u8d44\u8baf · 2026/6/22
• 评级变动
  H.C. Wainwright Maintains Adlai Nortye(ANL.US) With Buy Rating, Raises Target Price to $20
  \u5e02\u573a\u8d44\u8baf · 2026/4/20
• 公司公告
  AMSTEEL CORPORATION BERHAD: THE PROPOSED DISPOSALS OF THE ENTIRE ISSUED SHARE CAPITAL OF: (1)AMSTEEL SECURITIES (H.K.) LIMITED("ASL") (2)AMSTEEL FUTURES (H.K.) LIMITED("AFL") (3)AMSTEEL DERIVATIVES LIMITED ("ADL") (4)AMSTEEL NOMINEES (H.K.) LIMITED ("ANL")
  Bursa Malaysia · 2000/11/14
• 评级变动
  Analysts Offer Insights on Healthcare Companies: MetaVia (MTVA) and Adlai Nortye Ltd. Sponsored ADR (ANL)
  TipRanks · 2026/6/9
• Oppenheimer Maintains Adlai Nortye Group(ANL.US) With Buy Rating, Maintains Target Price $32
  \u5e02\u573a\u8d44\u8baf · 2026/8/27
• 评级变动
  Cantor Fitzgerald Initiates Adlai Nortye(ANL.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/6/22
• Jefferies Initiates Adlai Nortye Group(ANL.US) With Buy Rating, Announces Target Price $31
  \u5e02\u573a\u8d44\u8baf · 2026/9/10
• 评级变动
  Oppenheimer Initiates Adlai Nortye(ANL.US) With Buy Rating, Announces Target Price $32
  \u5e02\u573a\u8d44\u8baf · 2026/5/28
• Analysts Offer Insights on Healthcare Companies: Sysmex (OtherSSMXF) and Adlai Nortye Ltd. Sponsored ADR (ANL)
  TipRanks · 2026/8/27
• 评级变动
  Leerink Partners Initiates Adlai Nortye(ANL.US) With Buy Rating, Announces Target Price $23
  \u5e02\u573a\u8d44\u8baf · 2026/3/20
• Lucid Capital Initiates Adlai Nortye Group(ANL.US) With Buy Rating, Announces Target Price $49
  \u5e02\u573a\u8d44\u8baf · 2026/9/8
• 评级变动
  Analysts' Opinions Are Mixed on These Healthcare Stocks: US Physical Therapy (USPH) and Adlai Nortye Ltd. Sponsored ADR (ANL)
  TipRanks · 2026/8/15
• 评级变动
  Lucid Capital Initiates Adlai Nortye(ANL.US) With Buy Rating, Announces Target Price $11
  \u5e02\u573a\u8d44\u8baf · 2026/1/29
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Harmony Biosciences Holdings (HRMY) and Adlai Nortye Ltd. Sponsored ADR (ANL)
  TipRanks · 2026/7/16
• 评级变动
  JonesTrading Initiates Adlai Nortye(ANL.US) With Buy Rating, Announces Target Price $22
  \u5e02\u573a\u8d44\u8baf · 2026/7/27
• 评级变动
  JonesTrading Maintains Adlai Nortye(ANL.US) With Buy Rating, Maintains Target Price $22
  \u5e02\u573a\u8d44\u8baf · 2026/8/15
• H.C. Wainwright Maintains Adlai Nortye Group(ANL.US) With Buy Rating, Maintains Target Price $20
  \u5e02\u573a\u8d44\u8baf · 2026/9/9
• 评级变动
  H.C. Wainwright Upgrades Adlai Nortye(ANL.US) to Buy Rating, Announces Target Price $16
  \u5e02\u573a\u8d44\u8baf · 2026/2/13
• 评级变动
  H.C. Wainwright Maintains Adlai Nortye(ANL.US) With Buy Rating, Maintains Target Price $20
  \u5e02\u573a\u8d44\u8baf · 2026/8/14

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。